+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific Cat Vaccine Market Size, Share & Trends Analysis Report By Component, By Route of Administration (Injectables, Intranasal, and Oral), By Duration of Immunity, By Disease Type, By Type, By Country and Growth Forecast, 2024 - 2031

  • PDF Icon

    Report

  • 136 Pages
  • July 2024
  • Region: Asia Pacific
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5988561
The Asia Pacific Cat Vaccine Market is projected to witness market growth of 9.8% CAGR during the forecast period (2024-2031).

The China market dominated the Asia Pacific Cat Vaccine Market by Country in 2023, and is forecast to continue being a dominant market till 2031; thereby, achieving a market value of $175.1 million by 2031. The Japan market is registering a CAGR of 9.3% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 10.6% during (2024 - 2031).



In developing countries, where awareness and access to veterinary care can be more limited, international organizations and NGOs play a crucial role in education and outreach. For instance, in India, the World Veterinary Association (WVA) and local organizations like the Indian Veterinary Association (IVA) work to increase awareness about pet health. In rural areas, where veterinary services are frequently unavailable, they conduct vaccination initiatives and educational campaigns. These efforts include door-to-door campaigns, community meetings, and the distribution of educational pamphlets in local languages, which have been effective in raising awareness and increasing vaccination rates.

Advancements in veterinary medicine have also played a crucial role in expanding the market. Continuous research and development have led to more effective and safer vaccines. Innovations such as combination vaccines, which protect against multiple diseases with a single injection, have streamlined the vaccination process for veterinarians and pet owners. These advancements improve cat health outcomes and enhance the vaccination experience, making it more convenient and less stressful for pets and their owners.

The influence of social media cannot be underestimated in India's context. Veterinarians and animal rights activists use platforms like Facebook, Instagram, and YouTube to disseminate information about pet health and vaccinations. Prominent figures such as Maneka Gandhi, a well-known animal rights advocate, frequently discuss pet care and the necessity of vaccinations in her public addresses and social media posts. Her advocacy helps reach a wide audience, boosting awareness and acceptance of vaccination practices. Therefore, the region will present lucrative growth opportunities for market growth.

List of Key Companies Profiled

  • Zoetis, Inc.
  • Elanco Animal Health, Inc.
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Covetrus, Inc. (Clayton, Dubilier & Rice, LLC)
  • Virbac
  • Heska Corporation (Antech Diagnostics, Inc)
  • Ceva Sante Animale
  • Bioveta, a.s.

Market Report Segmentation

By Component
  • Combined Vaccines
  • Mono Vaccines
By Route of Administration
  • Injectables
  • Intranasal
  • Oral
By Duration of Immunity
  • 1 Year
  • 3 Year
  • Others
By Disease Type
  • Feline Respiratory Diseases
  • Feline Rabies
  • Feline Panleukopenia (Feline Distemper)
  • Feline Leukemia
  • Others
By Type
  • Modified/Attenuated Live
  • Inactivated (Killed)
  • Others
By Country
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Cat Vaccine Market, by Component
1.4.2 Asia Pacific Cat Vaccine Market, by Route of Administration
1.4.3 Asia Pacific Cat Vaccine Market, by Duration of Immunity
1.4.4 Asia Pacific Cat Vaccine Market, by Disease Type
1.4.5 Asia Pacific Cat Vaccine Market, by Type
1.4.6 Asia Pacific Cat Vaccine Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Strategies Deployed in Cat Vaccine Market
Chapter 5. Asia Pacific Cat Vaccine Market by Component
5.1 Asia Pacific Combined Vaccines Market by Country
5.2 Asia Pacific Mono Vaccines Market by Country
Chapter 6. Asia Pacific Cat Vaccine Market by Route of Administration
6.1 Asia Pacific Injectables Market by Country
6.2 Asia Pacific Intranasal Market by Country
6.3 Asia Pacific Oral Market by Country
Chapter 7. Asia Pacific Cat Vaccine Market by Duration of Immunity
7.1 Asia Pacific 1 Year Market by Country
7.2 Asia Pacific 3 Year Market by Country
7.3 Asia Pacific Others Market by Country
Chapter 8. Asia Pacific Cat Vaccine Market by Disease Type
8.1 Asia Pacific Feline Respiratory Diseases Market by Country
8.2 Asia Pacific Feline Rabies Market by Country
8.3 Asia Pacific Feline Panleukopenia (Feline Distemper) Market by Country
8.4 Asia Pacific Feline Leukemia Market by Country
8.5 Asia Pacific Others Market by Country
Chapter 9. Asia Pacific Cat Vaccine Market by Type
9.1 Asia Pacific Modified/Attenuated Live Market by Country
9.2 Asia Pacific Inactivated (Killed) Market by Country
9.3 Asia Pacific Others Market by Country
Chapter 10. Asia Pacific Cat Vaccine Market by Country
10.1 China Cat Vaccine Market
10.1.1 China Cat Vaccine Market by Component
10.1.2 China Cat Vaccine Market by Route of Administration
10.1.3 China Cat Vaccine Market by Duration of Immunity
10.1.4 China Cat Vaccine Market by Disease Type
10.1.5 China Cat Vaccine Market by Type
10.2 Japan Cat Vaccine Market
10.2.1 Japan Cat Vaccine Market by Component
10.2.2 Japan Cat Vaccine Market by Route of Administration
10.2.3 Japan Cat Vaccine Market by Duration of Immunity
10.2.4 Japan Cat Vaccine Market by Disease Type
10.2.5 Japan Cat Vaccine Market by Type
10.3 India Cat Vaccine Market
10.3.1 India Cat Vaccine Market by Component
10.3.2 India Cat Vaccine Market by Route of Administration
10.3.3 India Cat Vaccine Market by Duration of Immunity
10.3.4 India Cat Vaccine Market by Disease Type
10.3.5 India Cat Vaccine Market by Type
10.4 South Korea Cat Vaccine Market
10.4.1 South Korea Cat Vaccine Market by Component
10.4.2 South Korea Cat Vaccine Market by Route of Administration
10.4.3 South Korea Cat Vaccine Market by Duration of Immunity
10.4.4 South Korea Cat Vaccine Market by Disease Type
10.4.5 South Korea Cat Vaccine Market by Type
10.5 Singapore Cat Vaccine Market
10.5.1 Singapore Cat Vaccine Market by Component
10.5.2 Singapore Cat Vaccine Market by Route of Administration
10.5.3 Singapore Cat Vaccine Market by Duration of Immunity
10.5.4 Singapore Cat Vaccine Market by Disease Type
10.5.5 Singapore Cat Vaccine Market by Type
10.6 Malaysia Cat Vaccine Market
10.6.1 Malaysia Cat Vaccine Market by Component
10.6.2 Malaysia Cat Vaccine Market by Route of Administration
10.6.3 Malaysia Cat Vaccine Market by Duration of Immunity
10.6.4 Malaysia Cat Vaccine Market by Disease Type
10.6.5 Malaysia Cat Vaccine Market by Type
10.7 Rest of Asia Pacific Cat Vaccine Market
10.7.1 Rest of Asia Pacific Cat Vaccine Market by Component
10.7.2 Rest of Asia Pacific Cat Vaccine Market by Route of Administration
10.7.3 Rest of Asia Pacific Cat Vaccine Market by Duration of Immunity
10.7.4 Rest of Asia Pacific Cat Vaccine Market by Disease Type
10.7.5 Rest of Asia Pacific Cat Vaccine Market by Type
Chapter 11. Company Profiles
11.1 Zoetis, Inc.
11.1.1 Company Overview
11.1.2 Financial Analysis
11.1.3 Regional Analysis
11.1.4 Research & Development Expenses
11.1.5 Recent strategies and developments:
11.1.5.1 Partnerships, Collaborations, and Agreements:
11.1.5.2 Product Launches and Product Expansions:
11.1.5.3 Acquisition and Mergers:
11.1.6 SWOT Analysis
11.2 Elanco Animal Health, Inc.
11.2.1 Company Overview
11.2.2 Financial Analysis
11.2.3 Regional Analysis
11.2.4 Research & Development Expenses
11.2.5 SWOT Analysis
11.3 Merck & Co., Inc.
11.3.1 Company Overview
11.3.2 Financial Analysis
11.3.3 Segmental and Regional Analysis
11.3.4 Research & Development Expenses
11.3.5 SWOT Analysis
11.4 Boehringer Ingelheim International GmbH
11.4.1 Company Overview
11.4.2 Financial Analysis
11.4.3 Regional & Segmental Analysis
11.4.4 Research & Development Expenses
11.4.5 Recent strategies and developments:
11.4.5.1 Trials and Approvals:
11.4.6 SWOT Analysis
11.5 Covetrus, Inc. (Clayton, Dubilier & Rice, LLC)
11.5.1 Company Overview
11.5.2 SWOT Analysis
11.6 Virbac
11.6.1 Company Overview
11.6.2 Financial Analysis
11.6.3 Regional Analysis
11.6.4 Recent strategies and developments:
11.6.4.1 Acquisition and Mergers:
11.6.5 SWOT Analysis
11.7 Heska Corporation (Antech Diagnostics, Inc)
11.7.1 Company Overview
11.7.2 SWOT Analysis
11.8 Ceva Sante Animale
11.8.1 Company Overview
11.8.2 SWOT Analysis
11.9 Bioveta, a.s.
11.9.1 Company Overview

Companies Mentioned

  • Zoetis, Inc.
  • Elanco Animal Health, Inc.
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Covetrus, Inc. (Clayton, Dubilier & Rice, LLC)
  • Virbac
  • Heska Corporation (Antech Diagnostics, Inc)
  • Ceva Sante Animale
  • Bioveta, a.s.

Methodology

Loading
LOADING...